AUDHYA PAUL K. (Chief Medical Officer) sold 1.8% of their position (2.69K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $54.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/20/2026ACC: 0001860131-26-000004
Officer· Chief Medical Officer
Since May 2021
-2.69K
Net shares
Net seller
$54.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.25K acquired · 8.94K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
4.5%
4/16/2026
138.98K→145.23K
Common Stock
Direct
Shares
−2.69K
Price / share
$20.22
Trade value
$54.30K
% of position
1.8%
4/17/2026
145.23K→142.55K
Total
Net shares
+3.56K
Net value
-$54.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/16/2026 | M · Option Exercise | +6.25K | — | — | 4.5% | 138.98K | 145.23K |
| Common Stock Direct | 4/17/2026 | S · Sale | −2.69K | $20.22 | $54.30K | 1.8% | 145.23K | 142.55K |
| Total | +3.56K | -$54.30K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
93.75K
Exercisable
—
4/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock6.25K shares | 4/16/2026 | M · Option Exercise | −6.25K | — | 93.75K |